The review found no eligible studies for this question.
The intervention may leads to lower HSK recurrence in people with corneal graft (low certainty).
The intervention may leads to lower graft failure (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Summary of findings table: photocoagulation of drusen showed no clear difference in development of CNV compared with control (high certainty).
Summary of findings table: photocoagulation of drusen showed no clear difference in development of geographic atrophy compared with control (low certainty).
Summary of findings table: photocoagulation of drusen showed no clear difference in visual loss of 2‐3+ lines of visual acuity compared with control (moderate certainty).
Summary of findings table: photocoagulation of drusen showed no clear difference in loss of ≥ 0.3 log units of contrast sensitivity compared with control (low certainty).
Summary of findings table: photocoagulation of drusen leads to higher drusen reduction compared with control (high certainty).
Omega 3 fatty acids probably leads to higher loss of 3 or more lines of VA at 24 months compared with placebo (moderate certainty).
Omega 3 fatty acids probably leads to higher incidence of CNV at 24 months compared with placebo (moderate certainty).
Omega 3 fatty acids probably leads to higher incidence of CNV at 36 months compared with placebo (moderate certainty).
Omega 3 fatty acids showed no clear difference in progression of AMD over 5 years compared with placebo (high certainty).
Omega 3 fatty acids leads to higher adverse effects compared with placebo (high certainty).